المؤلفون: Creinin, MD, Cagnacci, A, Spaczyński, RZ, Stute, P, Chabbert-Buffet, N, Korver, T, Simoncini, T

مصطلحات موضوعية: Reproductive Medicine, Biomedical and Clinical Sciences, Prevention, Contraception/Reproduction, Clinical Research, Good Health and Well Being, oestrogens, oestetrol, E4, oral contraception, combined hormonal contraceptives, effectiveness, safety, non-contraceptive benefits, Biomedical and clinical sciences, Health sciences, Psychology

الوصول الحر: https://escholarship.org/uc/item/7wv9z59sTest

المؤلفون: Yusuf AM, Warsame MO, Gedi S, Abdullahi NA, Ahmed DI

المصدر: Open Access Journal of Contraception, Vol Volume 15, Pp 89-98 (2024)

مصطلحات موضوعية: hormonal contraceptives (hc), reproductive health, depression, somali women, cross-sectional study., Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/prevalence-of-depression-among-women-usingTest-hormonal-contraceptives-in--peer-reviewed-fulltext-article-OAJC; https://doaj.org/toc/1179-1527Test

الوصول الحر: https://doaj.org/article/840726a8814b446d9edbb9cfde0bdbecTest

المؤلفون: Nina Van Eekert, Naomi Biegel, Leen De Kort, Veronique Verhoeven, Thies Gehrmann, Caroline Masquillier, Sarah Ahannach, Sarah Lebeer

المصدر: BMC Women's Health, Vol 24, Iss 1, Pp 1-11 (2024)

مصطلحات موضوعية: Contraceptive use, Local hormonal contraceptives, Hormone free contraceptives, Educational gradient, Health behaviour, Fundamental cause theory, Gynecology and obstetrics, RG1-991, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1472-6874Test

الوصول الحر: https://doaj.org/article/c8b15e30a505453783e4945e17a9deedTest

المؤلفون: Wilson, Susan Frances, Ponzini, Matthew, Wilson, Machelle, Holton, Siri, Antell, Karen, Medaglio, Dominique

المصدر: Journal of Human Lactation. 39(1)

مصطلحات موضوعية: Reproductive Medicine, Biomedical and Clinical Sciences, Prevention, Pediatric, Behavioral and Social Science, Contraception/Reproduction, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Reproductive health and childbirth, Good Health and Well Being, Infant, Female, Humans, Breast Feeding, Medroxyprogesterone Acetate, Retrospective Studies, Prospective Studies, Contraception, Postpartum Period, Contraceptive Agents, breastfeeding, breastfeeding duration, breastfeeding experience, contraception, depot medroxyprogesterone acetate, feeding patterns, hormones, hormonal contraceptives, long-acting reversible contraceptives, maternal behavior, Clinical Sciences, Nursing, Public Health and Health Services, Pediatrics, Clinical sciences, Midwifery

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/8jv588cnTest

المؤلفون: Adriane Cristina Bovo, Priscila Grecca Pedrão, Yasmin Medeiros Guimarães, Luani Rezende Godoy, Júlio César Possati Resende, Adhemar Longatto Filho, Ricardo dos Reis

المصدر: Revista Brasileira de Ginecologia e Obstetrícia, Vol 45, Iss 12, Pp 818-823 (2024)

مصطلحات موضوعية: Oral hormonal contraceptives, Cervical cancer, HPV, Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

العلاقة: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032023001200818&lng=en&tlng=enTest; http://www.scielo.br/pdf/rbgo/v45n12/1806-9339-rbgo-45-12-0818.pdfTest; https://doaj.org/toc/0100-7203Test

الوصول الحر: https://doaj.org/article/3204ba9e1c8a4f71a81887d7d3540392Test

المؤلفون: Awel Turki, Almaz Ayalew, Andualem Mossie, Shimelis Mitiku

المصدر: Reproductive Health, Vol 20, Iss 1, Pp 1-12 (2023)

مصطلحات موضوعية: Hormonal contraceptives, Lipid profile, Depo-Medroxyprogesterone Acetate, Implant, Progesterone only pills, Southeast Ethiopia, Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1742-4755Test

الوصول الحر: https://doaj.org/article/bb14e97528b341dbaa6da7f507cf6708Test

المؤلفون: M. D. Creinin, A. Cagnacci, R. Z. Spaczyński, P. Stute, N. Chabbert-Buffet, T. Korver, T. Simoncini

المصدر: Frontiers in Global Women's Health, Vol 5 (2024)

مصطلحات موضوعية: oestrogens, oestetrol, E4, oral contraception, combined hormonal contraceptives, effectiveness, Gynecology and obstetrics, RG1-991, Women. Feminism, HQ1101-2030.7

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fgwh.2024.1395863/fullTest; https://doaj.org/toc/2673-5059Test

الوصول الحر: https://doaj.org/article/c431eba7bfe74a698bc0a1666067f8b5Test

المؤلفون: Guoqiang Zhang, Rani Basna, Maya B. Mathur, Cecilia Lässer, Roxana Mincheva, Linda Ekerljung, Göran Wennergren, Madeleine Rådinger, Bo Lundbäck, Hannu Kankaanranta, Bright I. Nwaru

المصدر: BMC Medicine, Vol 21, Iss 1, Pp 1-15 (2023)

مصطلحات موضوعية: Asthma, Bayesian estimation, Case–control, Hormonal contraceptives, Menopausal hormone therapy, Women, Medicine

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1741-7015Test

الوصول الحر: https://doaj.org/article/e795ee82822a40ca863c160ae72a16bdTest

المؤلفون: T. M. Reshetnyak, S. B. Kertchelaeva, N. M. Kosheleva, Т. М. Решетняк, С. Б. Керчелаева, Н. М. Кошелева

المساهمون: Статья подготовлена в рамках темы ФГБНУ НИИР им. В.А. Насоновой FURS-2022-003 (№ 122040400024-7).

المصدر: Rheumatology Science and Practice; Vol 62, No 1 (2024); 13-23 ; Научно-практическая ревматология; Vol 62, No 1 (2024); 13-23 ; 1995-4492 ; 1995-4484

مصطلحات موضوعية: системная красная волчанка, contraceptive methods, hormonal contraceptives, antiphospholipid syndrome, systemic lupus erythematosus, методы контрацепции, гормональные контрацептивы, антифосфолипидный синдром

وصف الملف: application/pdf

العلاقة: https://rsp.mediar-press.net/rsp/article/view/3510/2346Test; Обоскалова ТА (ред). Методы контрацепции и критерии их применения. Учебное пособие. Екатеринбург;2019.; Национальные медицинские критерии приемлемости методов контрацепции. Адаптированный документ «Медицинские критерии приемлемости использования методов контрацепции ВОЗ, 5-е издание, 2015». М.;2023.; Сухих ГТ, Прилепская ВН, Аганезова НВ, Андреева ЕН, Баранов ИИ, Долгушина НВ, и др. Контрацепция у женщин репродуктивного возраста. Учебное пособие. М.:Бином;2019.; Сумятина ЛВ. Современные гормональные контрацептивы: новые возможности выбора. Проблемы репродукции. 2014;(6): 46-48.; Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397-404. doi:10.1016/j.contraception.2011.01.021; Kestelman P, Trussell J. Efficacy of the simultaneous use of condoms and spermicides. Fam Plan Perspect. 1991;23(5):226-227,232.; Назарова НМ, Прилепская ВН. Эстроген-гестагенные рилизинг-системы: новый взгляд на контрацепцию (обзор литературы). Фарматека. 2009;(14):10-16.; Williams WV. Hormonal contraception and the development of autoimmunity: A review of the literature. Linacre Q. 2017;84(3): 275-295. doi:10.1080/00243639.2017.1360065; Iwata M, Oikawa Y, Shimizu Y, Sakashita N, Shoji A, Igarashi A, et al. Efficacy of low-dose estrogen-progestins and progestins in Japanese women with dysmenorrhea: A systematic review and network meta-analysis. Adv Ther. 2022;39(11):4892-4909. doi:10.1007/s12325-022-02298-9; Прилепская ВН. Новаринг – контрацепция, анатомия, сексология. Гинекология. 2004;6(6):306-308.; Прилепская ВН, Назарова НМ. Новые технологии в контрацепции: гормональные рилизинг-системы. Гинекология. 2005;7(1):41-44.; Khialani D, Rosendaal F, Vlieg AVH. Hormonal contraceptives and the risk of venous thrombosis. Semin Thromb Hemost. 2020;46(8):865-871. doi:10.1055/s-0040-1715793; Medical Eligibility Criteria for Contraceptive Use. 5th ed. Geneva: World Health Organization; 2015. https://ww.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/enTest/; Amy JJ, Tripathi V. Contraception for women: An evidence-based overview. BMJ. 2009;339:b2895. doi:10.1136/bmj.b2895; Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366(21):1998-2007. doi:10.1056/NEJMoa1110855; Kavanaugh ML, Pliskin E. Use of contraception among reproductive-aged women in the United States, 2014 and 2016. F S Rep. 2020;1(2):83-93. doi:10.1016/j.xfre.2020.06.006; Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2020;72(4):461-488. doi:10.1002/acr.24130; Насонов ЕЛ (ред.). Антифосфолипидный синдром. М.:Литтерра;2004.; Решетняк ТМ. Антифосфолипидный синдром: диагностика и клинические проявления (лекция). Научно-практическая ревматология. 2014;52(1):56-71. doi:10.14412/1995-4484-2014-56-71; Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306. doi:10.1111/j.1538-7836.2006.01753.x; Schwarz EB, Manzi S. Risk of unintended pregnancy among women with systemic lupus erythematosus. Arthritis Rheum. 2008;59(6):863-866. doi:10.1002/art.23712; Yazdany J, Trupin L, Kaiser R, Schmajuk G, Gillis JZ, Chakravarty E, et al. Contraceptive counseling and use among women with systemic lupus erythematosus: A gap in health care quality? Arthritis Care Res (Hoboken). 2011;63(3):358-365. doi:10.1002/acr.20402; Brunson MR, Klein DA, Olsen CH, Weir LF, Roberts TA. Postpartum contraception: Initiation and effectiveness in a large universal healthcare system. Am J Obstet Gynecol. 2017;217(1): 55.e1-55.e9. doi:10.1016/j.ajog.2017.02.036; Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, et al. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford). 2019;58(7):1259-1267. doi:10.1093/rheumatology/kez014; DeNoble AE, Hall KS, Xu X, Zochowski MK, Piehl K, Dalton VK. Receipt of prescription contraception by commercially insured women with chronic medical conditions. Obstet Gynecol. 2014;123(6):1213-1220. doi:10.1097/AOG.0000000000000279; Champaloux SW, Tepper NK, Curtis KM, Zapata LB, Whiteman MK, Marchbanks PA, et al. Contraceptive use among women with medical conditions in a nationwide privately insured population. Obstet Gynecol. 2015;126(6):1151-1159. doi:10.1097/AOG.0000000000001134; Birru Talabi M, Clowse MEB, Blalock SJ, Moreland L, Siripong N, Borrero S. Contraception use among reproductive-age women with rheumatic diseases. Arthritis Care Res (Hoboken). 2019;71(8):1132-1140. doi:10.1002/acr.23724; Danowski A, de Azevedo MN, de Souza Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol. 2009;36(6):1195-1199. doi:10.3899/jrheum.081194; Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56(7):2382-2391. doi:10.1002/art.22663; Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood. 2004;104(1):143-148. doi:10.1182/blood-2003-11-4085; Girolami A, Zanon E, Zanardi S, Saracino MA, Simioni P. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies. Blood Coagul Fibrinolysis. 1996;7(4):497-501. doi:10.1097/00001721-199606000-00011; Bacci S, Urquiola G, del Médico P, Sanabria JA, Bacci JC, Guzmán M, et al. Síndrome de Budd-Chiari, tromboembolismo pulmonar y trombosis venosa profunda, asociado con “anticoagulante lúpico” y uso reciente de anticonceptivos orales [Budd-Chiari syndrome, pulmonary thromboembolism, and deep venous thrombosis associated with “lupus anticoagulant” and recent use of oral contraceptives]. G E N. 1990;44(3):237-242 (In Spanish).; Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: A case-control study. Lancet Neurol. 2009;8(11):998-1005. doi:10.1016/S1474-4422(09)70239-X; Sammaritano LR.Which hormones and contraception for women with APS? Exogenous hormone use in women with APS. Curr Rheumatol Rep. 2021;23(6):44. doi:10.1007/s11926-021-01006-w; Iskander MK, Khan M. Chorea as the initial presentation of oral contraceptive related systemic lupus erythematosus. J Rheumatol. 1989;16(6):850-851.; Yamakami LY, de Araujo DB, Silva CA, Baracat EC, de Carvalho JF. Severe hemorrhagic corpus luteum complicating anticoagulation in antiphospholipid syndrome. Lupus. 2011;20(5):523-526. doi:10.1177/0961203310383300; Crétel E, Cacoub P, Huong DL, Gompel A, Amoura Z, Piette JC. Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: A report of three cases. Lupus. 1999;8(6):482-485. doi:10.1177/096120339900800614; ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107(6):1453-1472. doi:10.1097/00006250-200606000-00055; Pisoni CN, Cuadrado MJ, Khamashta MA, Hunt BJ. Treatment of menorrhagia associated with oral anticoagulation: Efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil). Lupus. 2006;15(12):877-880. doi:10.1177/0961203306071706; Rebelo RC, Pignaton E, Valeria Bahamondes M, Costallat LTL, Appenzeller S, Bahamondes L, et al. Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: Users of the 52-mg levonorgestrel-releasing intrauterine system. Arch Gynecol Obstet. 2019;299(6):1597-1605. doi:10.1007/s00404-019-05131-x; van Vlijmen EF, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR, et al. Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: A rational approach to contraception. Blood. 2011;118(8):2055-2061;quiz 2375. doi:10.1182/blood-2011-03-345678; Klok FA, Barco S. Optimal management of hormonal contraceptives after an episode of venous thromboembolism. Thromb Res. 2019;181(Suppl 1):1-5. doi:10.1016/S0049-3848(19)30357-3; Martinelli I, Lensing AW, Middeldorp S, Levi M, Beyer-Westendorf J, van Bellen B, et al. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use. Blood. 2016;127(11):1417-1425. doi:10.1182/blood2015-08-665927; Паневин ТС, Попкова ТВ, Решетняк ТМ, Кошелева НМ, Ледина АВ. Менопаузальная гормонотерапия при системной красной волчанке: Pro et contra. Научно-практическая ревматология. 2023;61(1):70-76. doi:10.47360/1995-4484-2023-70-76; The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728-753. doi:10.1097/GME.0000000000000921; U.S. Preventive Services Task Force. Hormone therapy for the prevention of chronic conditions in postmenopausal women: Recommendations from the U.S. Preventive Services Task Force. Ann Intern Med. 2005;142(10):855-860.; Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362(9382):419-427. doi:10.1016/s0140-6736(03)14065-2; Менопауза и климактерическое состояние у женщин: Клинические рекомендации МЗ РФ. М.;2021. [Menopause and climacteric condition in women. Clinical recommendations of the Ministry of Health of the Russian Federation. Moscow;2021 (In Russ.)].; Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, et al.; Women’s Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292(13):1573-1580. doi:10.1001/jama.292.13.1573; Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2012;(7):CD004143. doi:10.1002/14651858; Smith NL, Heckbert SR, Lemaitre RN, Reiner AP, Lumley T, Weiss NS, et al. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA. 2004;292(13):1581-1587. doi:10.1001/jama.292.13.1581; Sweetland S, Beral V, Balkwill A, Liu B, Benson VS, Canonico M, et al.; Million Women Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost. 2012;10(11):2277-2286. doi:10.1111/j.1538-7836.2012.04919.x; Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, et al.; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration. Circulation. 2005; 112(22):3495-3500. doi:10.1161/CIRCULATIONAHA.105.565556; Rosendaal FR, Vessey M, Rumley A, Daly E, Woodward M, Helmerhorst FM, et al. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol. 2002;116(4):851-854. doi:10.1046/j.0007-1048.2002.03356.x; Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, et al.; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: The ESTHER study. Circulation. 2007;115(7):840-845. doi:10.1161/CIRCULATIONAHA.106.642280; Rovinski D, Ramos RB, Fighera TM, Casanova GK, Spritzer PM. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thromb Res. 2018;168:83-95. doi:10.1016/j.thromres.2018.06.014; Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: Systematic review and meta-analysis. BMJ. 2008;336(7655):1227-1231. doi:10.1136/bmj.39555.441944.BE; Pinkerton JV, James AH. Management of menopausal symptoms for women who are at high risk of thrombosis. Clin Obstet Gynecol. 2018;61(2):260-268. doi:10.1097/GRF.0000000000000358; Krause MS, Nakajima ST. Hormonal and nonhormonal treatment of vasomotor symptoms. Obstet Gynecol Clin North Am. 2015;42(1):163-179. doi:10.1016/j.ogc.2014.09.008; Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, et al. Nonhormonal therapies for menopausal hot flashes: Systematic review and meta-analysis. JAMA. 2006;295(17):2057-2071. doi:10.1001/jama.295.17.2057; Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013;20(9):888-902;quiz 903-904. doi:10.1097/GME.0b013e3182a122c2; Bhupathiraju SN, Grodstein F, Stampfer MJ, Willett WC, Crandall CJ, Shifren JL, et al. Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study. Menopause. 2018;26(6):603-610. doi:10.1097/GME.0000000000001284; de Melo AS, Dos Reis RM, Ferriani RA, Vieira CS. Hormonal contraception in women with polycystic ovary syndrome: Choices, challenges, and noncontraceptive benefits. Open Access J Contracept. 2017;8:13-23. doi:10.2147/OAJC.S85543; Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018;51:68-91. doi:10.1016/j.bpobgyn.2018.01.015; Yuk JS, Song JY, Lee JH, Park WI, Ahn HS, Kim HJ. Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: A meta-analysis. Ann Surg Oncol. 2017;24(5):1322-1329. doi:10.1245/s10434-016-5699-9; Grandone E, Di Micco PP, Villani M, Colaizzo D, FernándezCapitán C, Del Toro J, et al.; RIETE Investigators. Venous thromboembolism in women undergoing assisted reproductive technologies: Data from the RIETE registry. Thromb Haemost. 2018;118(11):1962-1968. doi:10.1055/s-0038-1673402; Machin N, Ragni MV. Hormones and thrombosis: Risk across the reproductive years and beyond. Transl Res. 2020;225:9-19. doi:10.1016/j.trsl.2020.06.011; Xu X, Chlebowski RT, Shi J, Barac A, Haque R. Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors. Breast Cancer Res Treat. 2019;174(3):785-794. doi:10.1007/s10549-018-05086-8; Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: A cohort study. Ann Intern Med. 2018;169(4):205-213. doi:10.7326/M17-2785; Goldstein Z, Khan M, Reisman T, Safer JD. Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy. J Blood Med. 2019;10:209-216. doi:10.2147/JBM.S166780; Duan B, Zhang Y, Wang X, Zhang Y, Hou Y, Bai J, et al. Effect of megestrol acetate combined with oral nutrition supplement in malnourished lung cancer patients: A single-center prospective cohort study. Front Nutr. 2021;8:654194. doi:10.3389/fnut.2021.654194; Poulter NR, Chang CL, Farley TM, Meirik O. Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications. Lancet. 1999;354(9190):1610. doi:10.1016/s0140-6736(99)03132-3; Аномальные маточные кровотечения. Клинические рекомендации МЗ РФ. М.;2021. [Abnormal uterine bleeding. Clinical recommendations of the Ministry of Health of the Russian Federation. Moscow;2021 (In Russ.)].; https://rsp.mediar-press.net/rsp/article/view/3510Test

الإتاحة: https://doi.org/10.47360/1995-4484-2024-13-23Test
https://doi.org/10.1016/j.contraception.2011.01.021Test
https://doi.org/10.1080/00243639.2017.1360065Test
https://doi.org/10.1007/s12325-022-02298-9Test
https://doi.org/10.1055/s-0040-1715793Test
https://doi.org/10.1136/bmj.b2895Test
https://doi.org/10.1056/NEJMoa1110855Test
https://doi.org/10.1016/j.xfre.2020.06.006Test
https://doi.org/10.1002/acr.24130Test
https://doi.org/10.14412/1995-4484-2014-56-71Test

المؤلفون: Barros, Camilla Rayza dos Santos, Martins, Jullia Ingrid Rodrigues, Silva, Lorrane Mikaele de Sousa, Carvalho, Glaucia Lemes de, Pedreira, Angela Guimaraes

المصدر: Revista Ibero-Americana de Humanidades, Ciências e Educação; Vol. 10 No. 4 (2024): Revista Ibero-Americana de Humanidades, Ciências e Educação- REASE ; 589-598 ; Revista Ibero-Americana de Humanidades, Ciências e Educação; v. 10 n. 4 (2024): Revista Ibero-Americana de Humanidades, Ciências e Educação- REASE ; 2675-3375 ; 10.51891/rease.v10i4

مصطلحات موضوعية: Anticoncepcionais. Comorbidades. Mulheres. Contraceptivos hormonais, Contraceptives. Risk factors. Comorbidities. Women. Hormonal contraceptives

وصف الملف: application/pdf

العلاقة: https://periodicorease.pro.br/rease/article/view/13481/6557Test; https://periodicorease.pro.br/rease/article/view/13481Test

الإتاحة: https://doi.org/10.51891/rease.v10i4.13481Test
https://doi.org/10.51891/rease.v10i4Test
https://periodicorease.pro.br/rease/article/view/13481Test